Anaesthesia · free tool
Guideline Finder
The guidelines and ANZCA statements your exam answers should name: what each recommends, a sentence you can write to cite it, what changed recently and the outdated answer to avoid. Quiz yourself, flip flashcards, print a cheat sheet. Free, no sign-up.
40 guidelines · 27 from ANZCA · 8 recently changed · checked 2026-11
You know 0%
ANZCA exam guideline cheat sheet · checked 2026-11 · fellowshipready.com.au
Pre-anaesthesia consultation and patient preparation: PG07 Guideline on pre-anaesthesia consultation and patient preparation (ANZCA, PG07 2024 (Appendix 1, 2026)). Consultation should happen early enough to allow assessment, optimisation, planning and discussion; shared decision-making is central. It should not be omitted unless delay would put the patient's overall welfare at risk. Covers medical assessment and optimisation, a perioperative plan, informed consent and written documentation. Risk stratification and any advance care directive should be considered.
Adult preoperative fasting and Sip Til Send: PG07 Guideline on pre-anaesthesia consultation and patient preparation: Appendix 1 (fasting) (ANZCA, PG07 2024 (Appendix 1, 2026)). Adults: a light, low-calorie meal may be taken up to 6 hours before anaesthesia. Low-risk adults may use 'Sip Til Send' (up to about 200 mL per hour of clear fluid) where the facility has a policy; otherwise clear fluids are encouraged until 2 hours before. Sip Til Send is not recommended for patients with risk factors for delayed gastric emptying (e.g. GLP-1 receptor agonists). Regular medications can be taken with a 30 mL sip of water; milk is not a clear fluid.
Paediatric fasting: clear fluids, breast milk and formula: PG07 Guideline on pre-anaesthesia consultation and patient preparation: Appendix 1 (fasting) (ANZCA, PG07 2024 (Appendix 1, 2026)). Children (to 16 years): clear fluids up to 3 mL/kg/h until 1 hour before anaesthesia. Breast milk up to 3 hours before. Formula or non-human milk up to 4 hours before for infants under 12 months (volume-limited); after 12 months milk is treated like solids (6 hours). Light meal up to 6 hours before.
Procedural sedation: staffing and monitoring: PG09(G) Guideline on procedural sedation (ANZCA, PG09(G) 2023). Covers minimal and moderate sedation; deep sedation is out of scope because it can slide into general anaesthesia. For sedation beyond minimal: a proceduralist, a sedationist and at least one additional staff member; with IV agents such as propofol, one practitioner must be solely responsible for sedation. Continuous pulse oximetry for all; waveform capnography strongly advised for moderate sedation and for ASA 3–4 patients. Moderate sedation needs someone with age-appropriate advanced life support skills immediately available; an anaesthetist should sedate sick patients or complex cases.
Minimum monitoring during anaesthesia: PG18 Guideline on monitoring during anaesthesia (ANZCA, PG18 2025). Oxygen analyser with low-oxygen alarm whenever a breathing system is in use; pulse oximetry with audible tone for every patient under GA or sedation. Quantitative waveform capnography for every GA and immediately available for sedation; circulation recorded at least every 10 minutes. Quantitative neuromuscular monitoring should be available whenever neuromuscular blockers are used and used before extubation after non-depolarising block. Core temperature monitoring available for every GA and used when active warming is used; alarms on from the start.
Post-anaesthesia care unit staffing and handover: PS04(A) Position statement on the post-anaesthesia care unit (ANZCA, PS04(A) 2020). Every patient is observed one-to-one by a PACU nurse until they regain control of their airway, with a second nurse immediately available. Higher ratios (2:1) may be needed on arrival or for unstable patients or those needing airway support. The anaesthetist gives a formal handover and stays nearby until the patient is stable and the nurse has accepted care; do not hand over an unstable patient. The anaesthetist holds authority for discharge from PACU against written discharge criteria.
Day surgery: selection and discharge: PG15(POM) Guideline for the perioperative care of patients selected for day stay procedures (ANZCA, PG15(POM) 2018). Suitable patients are ASA 1–2 or medically stable ASA 3–4; ASA alone does not decide suitability. Facilities set a BMI above which early anaesthetic review is triggered (above 35 kg/m² is common); OSA patients should need minimal postoperative opioid. A responsible adult must take the patient home by suitable vehicle (not public transport) and stay at least overnight. Written and verbal instructions, including an emergency contact number; a pre-arranged pathway for unplanned admission.
Informed consent for anaesthesia and material risk: PS26(A) Position statement on informed consent for anaesthesia or sedation (ANZCA, PS26(A) 2021). Disclose risks a reasonable person in the patient's position would consider significant, and those this particular patient would likely attach significance to (the Australian material-risk test). Explain both common minor risks and rare serious ones, alternatives including no treatment, and blood product issues. Ideally obtained by the anaesthetist giving the anaesthetic; document the discussion, not just a signature. Use a qualified interpreter, not a family member; in emergencies proceed to save life and explain afterwards.
Ex-premature infants and day-case discharge: PG29(A) Guideline for the provision of anaesthesia care to children (ANZCA, PG29(A) 2020). Ex-preterm infants at risk of postoperative apnoea should not go home the same day unless medically fit and at least 54 weeks postmenstrual age. Term infants: same-day discharge only if fit and at least 46 weeks postmenstrual age. Children should be anaesthetised by anaesthetists trained and current in paediatric care; consider a second experienced anaesthetist for high-risk cases. Child-friendly areas, a dedicated paediatric PACU space and 1:1 nursing until awake; parents may attend induction.
Checking the anaesthesia machine: PG31 Guideline on checking anaesthesia delivery systems (ANZCA, PG31 2026 (pilot)). Three levels of check: level one (detailed, before first use and after service), level two (start of each list) and level three (before each patient). Level two covers high-pressure supply (reserve oxygen cylinder at least a quarter full, pipeline pressures), low-pressure leaks, breathing system leak test and two-bag test, ventilator alarms, scavenging and a backup means of ventilation. The anaesthetist is responsible for the level two check but may delegate it to a trained person; checks are documented. Level three before each patient includes vaporiser, CO2 absorber, any changed breathing system and ventilator settings.
Syringe labelling and drug errors: PG51(A) Guideline for the safe management and use of medications in anaesthesia (ANZCA, PG51(A) 2021). Use pre-printed, colour-coded labels to ISO 26825 (and the Australian user-applied labelling standard); handwritten labels only as a temporary measure. Draw up one drug from one ampoule into one syringe at a time; if interrupted, discard and restart; recheck before giving. Store emergency and less-used potent drugs apart from routine drugs; separate look-alike packaging and concentrations. Red syringes are strongly encouraged for neuromuscular blockers; intrathecal drugs need a second-person check; keep empty ampoules until the end of the case.
Transport of the critically ill patient: PG52 Guideline for transport of critically ill patients (ANZCA / ACEM / CICM, PG52 2025). Jointly issued by ANZCA, ACEM (G03) and CICM (IC-10). Retrieval teams have at least two clinicians with appropriate scope; intra-hospital transfer minimum is a doctor, a registered nurse and an orderly. Continuous waveform capnography for every ventilated or sedated patient, plus ECG, BP, SpO2 and other monitoring with audible and visual alarms. Carry oxygen with a 50–100% buffer (at least 20% for other consumables) over the expected journey time; formal handover at both ends and a pre-departure checklist.
Difficult airway trolley and eFONA kit: PG56 Guideline on equipment to manage difficult airways (ANZCA, PG56 2025). Every difficult airway trolley carries videolaryngoscopy with both Macintosh-style and hyperangulated blades, and second-generation SADs (sizes 3–5). Emergency front-of-neck access must be immediately available wherever airways are managed, with both scalpel–bougie and cannula techniques (e.g. size 10 blade, bougie, 6.0 mm tube). Trolleys standardised across the facility, able to reach any point of care within one minute, stocked with cognitive aids and an airway alert letter template. Immediate waveform capnography wherever airway management occurs; sugammadex stored nearby, secure but unlocked.
Can't intubate, can't oxygenate (CICO): PG61(A) Guideline for the management of evolving airway obstruction: transition to the Can't Intubate Can't Oxygenate airway emergency (ANZCA, PG61(A) 2017). Declare CICO aloud when best efforts at intubation, facemask and supraglottic airway have all failed and oxygenation is falling or persistently low; start infraglottic rescue immediately. Best effort: up to three optimised intubation attempts, two SAD attempts (different size or type) and an optimised facemask (two-person, adjuncts). Call for help after one failed pathway; mobilise for infraglottic rescue when two have substantially failed; SpO2 below 90% should escalate concern. Rehearse as a team with shared cognitive aids and standardised equipment.
Care of patients sedated for acute behavioural disturbance: PG63(A) Guideline for safe care for patients sedated in health care facilities for acute behavioural disturbance (ANZCA, PG63(A) 2019). At least three trained staff: a medical practitioner with airway and ALS skills, a nurse to monitor and a further staff member for behaviour. Pulse oximetry for every sedated patient; ECG and NIBP available; continuous observation of ventilation with capnography when indicated. Routinely score sedation depth with a tool such as RASS. Care in an area equipped for resuscitation, with a low threshold to involve an anaesthetist for high-risk patients.
Limitations of treatment and DNR orders in theatre: PG67(G) Guideline for the care of patients at the end-of-life who are considered for surgery or interventional procedures (ANZCA, PG67(G) 2022). Limitations of medical treatment are not automatically suspended: decide explicitly to continue, modify or suspend them for the perioperative period. Agree in advance when any suspended or modified limitation will be reinstated. Clarify the intent of surgery and set shared goals of care; use best-case/worst-case discussions and consider advance care directives. Document the decision and who was involved.
Perioperative anaphylaxis: immediate management: ANZCA/ANZAAG Perioperative Anaphylaxis Management Guidelines (ANZCA / ANZAAG, 2022 (version 14 November 2022)). Six cards: adult and paediatric immediate and refractory management, differential diagnosis, post-crisis management. Adult IV adrenaline (1 mg in 10 mL): start 10–20 micrograms, escalating to 50–100 micrograms then 200 micrograms every 1–2 minutes as needed; IM 500 micrograms if no IV access or monitoring. Crystalloid 500 mL (moderate) to 1000 mL (life-threatening) boluses. Start an adrenaline infusion after more than three boluses; if still unresponsive, move to the refractory card.
After perioperative anaphylaxis: tryptase and referral: PG69 Guideline on the prevention, investigation and follow up of perioperative hypersensitivity reactions and anaphylaxis (ANZCA, PG69 2025). Four tryptase samples: as soon as practical, then at 1 hour, 4 hours and after 24 hours (baseline). The treating anaesthetist refers every suspected case (adults and children) to a perioperative drug allergy service, even without a tryptase rise. Disclose to the patient, document a drug alert, write to the GP, report to WebAIRS and to TGA (Australia) or CARM (NZ). Until tested, avoid all IV drugs given within 60 minutes of onset (and other routes within 2 hours), including all neuromuscular blockers and chlorhexidine.
Acute pain management and opioid stewardship: PS41(G) Position statement on acute pain management (ANZCA, PS41(G) 2023). Multimodal analgesia to reduce opioid need; assess function, not pain scores alone. Avoid routine modified-release opioids for acute pain. Discharge opioid supply based on use in the previous 24 hours; none if none was used; ideally under 7 days and no repeats. Sedation is the key early sign of opioid-induced ventilatory impairment; titrate to keep the sedation score below 2.
Fatigue risk management: PG43 Guideline on fatigue risk management in anaesthesia and perioperative medicine practice (ANZCA, PG43 2020). Anaesthetists should not work more than 16 hours in 24. At least 8 hours off between shifts for commuting, hygiene and sleep. Elective lists should finish by 10 pm; avoid starting non-emergency surgery after 10 pm. Individuals must recognise fatigue in themselves and others; hospitals should offer safe transport (e.g. taxi vouchers) for fatigued staff.
The anaesthetic assistant: PS08 Position statement on the assistant for the anaesthetist (ANZCA, PS08 2026). A trained assistant dedicated to the anaesthetist must be present for preparation and induction, and again at emergence. During maintenance an assistant must be immediately available. Every case involving anaesthesia should be rostered with an assistant. Trainee assistants should not work unsupervised after hours.
Major regional anaesthesia: safety standards: PG03 Guideline for the management of major regional anaesthesia and analgesia (ANZCA, PG03 2026 (pilot)). Consent per PS26(A), IV access before starting, and an assistant per PS08. Stop Before You Block: confirm site and side with a second clinician after positioning and before skin prep. Lipid emulsion immediately available wherever local anaesthetic toxicity is possible; monitor for at least 30 minutes after the block. Assess anticoagulant and bleeding risk before every neuraxial technique; prefer MRI to investigate a new neurological deficit.
Malignant hyperthermia: dantrolene stock and dose: PS55 Position statement on minimum facilities for safe administration of anaesthesia: Appendix 2 (malignant hyperthermia) (ANZCA, PS55 2021 (Appendix 2, 2026)). At least 720 mg of dantrolene must be immediately available wherever triggering agents are used. A further 480 mg must be obtainable within one hour; remote sites unable to do this should hold at least 1200 mg. Initial dose 2.5 mg/kg actual body weight, capped at 300 mg per dose. Aligned with updated European MH Group guidance and developed with MH Australia & New Zealand.
GLP-1 receptor agonists before anaesthesia: Clinical practice recommendations on the periprocedural use of GLP-1 RAs and GLP-1/GIP RAs (ANZCA / ADS / GESA / NACOS / ANZMOSS, April 2025). Continue GLP-1 RAs: do not withhold them before the procedure. A 24-hour clear fluid diet from waking the day before, then the standard 6-hour fast, to reduce residual gastric contents. Sip Til Send is not recommended for these patients. No fasting regimen guarantees an empty stomach; patients on insulin need endocrinology advice.
SGLT2 inhibitors and perioperative ketoacidosis: Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use in People with Diabetes (alert) (ADS / ADEA / ANZCA, May 2023 update). For surgery needing at least one night in hospital, or bowel preparation, stop the SGLT2 inhibitor for 2 days before and on the day of the procedure. For day procedures without bowel prep, withhold on the day only. Check blood (not urine) ketones; ketoacidosis can occur with normal glucose (euglycaemic DKA). Restart only when eating and drinking normally.
Clinical handover between anaesthetists: PS53 Position statement on clinical handover responsibilities (ANZCA, PS53 2026 (pilot)). Hand over when the patient is stable, with focus and minimal distraction, using the institution's standard tool. Cover identity, health status, technique, airway, lines, fluids, events, plan, surgical progress and equipment checks. Tell the surgeon (and, for a trainee, the consultant) about the handover. Responsibility only transfers when the receiving practitioner accepts it; in temporary relief the reliever should not substantially change management without conferring.
Perioperative POCUS including gastric ultrasound: PG47 Guideline on training and practice of perioperative diagnostic point-of-care ultrasound (POCUS) (ANZCA, PG47 2025). Core modalities: focused cardiac, lung, gastric and upper airway ultrasound, each with minimum supervised case numbers. Gastric ultrasound is mainly qualitative (low vs high aspiration risk); an empty stomach can only be called in the right lateral decubitus position. POCUS extends clinical examination and should not be the sole basis for decisions; capnography remains the gold standard for tube confirmation. Document a report (indication, findings, image quality, limitations, recommendations) and store images where possible.
Adult cardiac arrest: ALS algorithm: ANZCOR Guideline 11.2: Protocols for Adult Advanced Life Support (ANZCOR (Australian Resuscitation Council / NZ Resuscitation Council), Approved June 2024). Two-minute loops of 30:2 CPR at 100–120/min, at least 5 cm deep; minimise pauses. Adrenaline 1 mg: as soon as feasible in non-shockable rhythms; after the second shock in VF/pVT; then every second loop (about 4 minutes). Amiodarone 300 mg after the third shock for refractory VF/pVT (lidocaine an alternative). IV preferred over IO; waveform capnography to confirm airway and monitor CPR; treat the 4 Hs and 4 Ts.
Local anaesthetic systemic toxicity (LAST): ANZCOR Guideline 11.10: Resuscitation in Special Circumstances (ANZCOR, Current online version (accessed 2026)). 20% lipid emulsion 1.5 mL/kg IV bolus, then infusion at 15 mL/kg/h. Up to three boluses at 5-minute intervals; continue until stable or a total of 12 mL/kg. ANZCA PG03 adds that in LAST arrest standard ANZCOR ALS adrenaline (1 mg) is used alongside lipid. Same guideline covers hyperkalaemia, hypothermia, tension pneumothorax and arrest in pregnancy (left uterine displacement).
Major haemorrhage protocol: Patient blood management guideline for adults with critical bleeding (National Blood Authority, 2023 (minor update September 2025)). Every institution should have a major haemorrhage protocol. In a ratio-based MHP, use no less than 2:1:1 RBC:FFP:platelets; evidence does not favour 1:1:1 over 2:1:1. Tranexamic acid early (within 3 hours) in trauma; may be considered within 3 hours in obstetric haemorrhage; not recommended for GI bleeding. Monitor and correct: temperature below 35°C, pH below 7.2, ionised calcium below 1 mmol/L, fibrinogen below 2.0 g/L (give 3–4 g).
Preoperative anaemia, iron and tranexamic acid: Patient Blood Management Guidelines: Module 2 – Perioperative (National Blood Authority, Module 2 (2012), under review). Identify, evaluate and manage preoperative anaemia; schedule elective surgery to allow optimisation. Give iron if ferritin is below 100 µg/L and substantial blood loss is expected; ESAs must be combined with iron. IV tranexamic acid in cardiac surgery, and in non-cardiac surgery where large blood loss is expected; cell salvage when substantial loss is anticipated. Don't transfuse on Hb alone: likely inappropriate above 80 g/L without ischaemia and not at 100 g/L or more; give single units and reassess.
Cardiac risk assessment for non-cardiac surgery: 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery (European Society of Cardiology, 2022). High-sensitivity troponin before and at 24 and 48 hours after intermediate/high-risk surgery in patients with CVD, risk factors or age 65 or more; BNP/NT-proBNP should be considered. Routine biomarkers are not recommended in low-risk patients having low/intermediate-risk surgery. Delay elective surgery 6 months after elective PCI and 12 months after ACS. Typical P2Y12 interruption: ticagrelor 3–5 days, clopidogrel 5 days, prasugrel 7 days.
Neuraxial blocks and anticoagulants: Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: ASRA Pain Medicine Evidence-Based Guidelines (fifth edition) (American Society of Regional Anesthesia and Pain Medicine, 5th edition (2025, Reg Anesth Pain Med)). The standard international reference for timing neuraxial and deep blocks around anticoagulants. The 5th edition replaces 'prophylactic' and 'therapeutic' with 'low dose' and 'high dose' anticoagulant categories. Interruption times are individualised to renal function and thrombotic risk, with expanded DOAC guidance and drug-specific assays. Deep plexus and peripheral blocks are distinguished more precisely from neuraxial blocks.
Unanticipated difficult intubation algorithm: Difficult Airway Society 2025 guidelines for management of unanticipated difficult tracheal intubation in adults (Difficult Airway Society (UK), 2025 (Br J Anaesth)). Replaces the 2015 DAS algorithm. Videolaryngoscopy as first-line where available. Emphasises oxygenation throughout (high-flow nasal oxygen, head-up positioning) and limited attempts before moving to a supraglottic airway. In 'cannot intubate, cannot oxygenate', proceed to emergency front-of-neck airway without delay.
Pre-eclampsia: blood pressure and magnesium: SOMANZ Hypertension in Pregnancy Guideline 2023 (Society of Obstetric Medicine of Australia and New Zealand, 2023). Severe hypertension is 160/110 mmHg or more and needs urgent treatment (IV hydralazine, IV labetalol, oral immediate-release nifedipine or IV diazoxide). Magnesium sulfate for eclampsia: 4 g IV load then 1 g/h for 24 hours or 24 hours after the last seizure. Magnesium for fetal neuroprotection when pre-eclampsia risks birth before 30 weeks. Aspirin 150 mg at night from before 16 weeks for high-risk women; steroids if birth is likely before 34 weeks.
Postpartum haemorrhage: uterotonics and TXA: Management of Postpartum Haemorrhage (C-Obs 43) (RANZCOG, C-Obs 43, November 2021 (review due November 2026)). PPH is 500 mL or more; severe is 1000 mL or more or any loss with haemodynamic compromise; think Tone, Trauma, Tissue, Thrombin. Oxytocin 5 units slow IV then infusion; ergometrine 0.25 mg (max 1 mg); carboprost 0.25 mg IM every 15 minutes or more (max 2 mg, avoid in asthma). Tranexamic acid 1 g IV as soon as possible, repeated after 30 minutes if bleeding continues. Replace fibrinogen when below 1.5–2 g/L; every obstetric unit needs a known massive transfusion protocol.
Severe traumatic brain injury targets: Guidelines for the Management of Severe Traumatic Brain Injury, 4th Edition (Brain Trauma Foundation, 4th edition (2016)). Keep SBP at least 100 mmHg (age 50–69) or 110 mmHg (15–49 or over 70). Treat ICP above 22 mmHg; target CPP 60–70 mmHg. Avoid prolonged prophylactic hyperventilation to PaCO2 25 mmHg or less, especially in the first 24 hours. Steroids not recommended; phenytoin for early (7-day) seizure prophylaxis; bifrontal craniectomy not recommended for diffuse injury.
Opioid prescribing at discharge: Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard (Australian Commission on Safety and Quality in Health Care, 2022). Nine quality statements, from shared decision-making through to transfer of care. Opioid-naive patients: immediate-release, lowest dose, shortest time; modified-release use should be exceptional. Discharge supply generally no more than 7 days for inpatients and 3 days from ED, guided by the previous 24 hours' oMEDD. Monitor sedation (score 2 = early respiratory depression); hand over a pain plan to the GP.
Postoperative delirium: Delirium Clinical Care Standard (Australian Commission on Safety and Quality in Health Care, 2021). Screen at-risk patients for cognitive impairment and assess delirium with a validated tool such as the 4AT. Multicomponent non-drug prevention: reorientation, glasses and hearing aids, mobilisation, hydration, sleep, pain control. Antipsychotics are not recommended to treat delirium; only short-term for imminent risk of harm, lowest dose; avoid benzodiazepines. Avoid physical restraint; send a care plan to the GP within 48 hours of discharge.
Hip fracture: analgesia and timing of surgery: Hip Fracture Clinical Care Standard (Australian Commission on Safety and Quality in Health Care, 2023). Assess pain on arrival and reassess within 30 minutes of analgesia. Multimodal analgesia including a nerve block unless contraindicated. Surgery within 36 hours of first presentation if clinically indicated. Screen cognition on arrival, assess delirium after surgery, and mobilise without weight-bearing restriction on the day of or day after surgery.
Summaries are written in our own words from each guideline's official page and are for exam study, not clinical use. Guidelines change: check the source before you rely on it.
Try 20 free questions.
ANZCA-style questions, marked with a reason for every option. Free account, no card.
Also free: Anatomy Scroller · ANZCA exam guides